EcoR1 Capital LLC 13D and 13G filings for Eton Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-09 4:04 pm Purchase | 2024-12-02 | 13G | Eton Pharmaceuticals, Inc. ETON | EcoR1 Capital LLC | 1,397,669 5.400% | 1,397,669 (New Position) | Filing |